Caplin Point Laboratories Limited (CAPLIPOINT)
ISIN: INE475E01026 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
755.45
1.2(0.16%)

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic droppers, prefilled bags, tablets, dry syrups, soft gels, capsules, suppositories, liquid syrups in bottles, liquid injectables in ampoules and vials, prefilled syringes, emulsion injection in ampoules and vials, topicals, and sachets. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.

Pricing Updates

TODAY'S HIGH

759

TODAY'S LOW

747.55

52 WEEK HIGH

888

52 WEEK LOW

626

Major Holders

% of Shares Held by
All Insider

74.13%

% of Shares Held by
Institutions

1.94%

% of Float Held by
Institutions

7.50%

Number of Institutions
Holding Shares

19

Company Overview

MARKET CAP

5726.34 Cr.

ETERPRISE VALUE

5219.76 Cr.

NO. OF SHARES

7.58 Cr.

BOOK VALUE

212.559

DIV. YIELD

2%

DEBT

2.31 Cr.

GROSS PROFIT

698.56 Cr.

CASH

601.97 Cr.

REVENUE

1372.35 Cr.

REVENUE/SHARE

181.117

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-199.36 Cr.51.57 Cr.14.62 Cr.-23.46 Cr.
Change To Liabilities83.77 Cr.26.98 Cr.31.24 Cr.-28.46 Cr.
Total cashflows from Investing Activities-270.94 Cr.-5.35 Cr.-54.50 Cr.-100.45 Cr.
Net Borrowings-16.56 Cr.-19.41 Cr.-21.53 Lakhs-3.51 Lakhs
Total Cash from Financing Activities-40.71 Cr.-23.97 Cr.79.76 Cr.89.78 Cr.
Other Liabilities7.23 Cr.-40.61 Cr.29.34 Cr.-48.68 Cr.
Total Assets0025 k54 k
Net Income299.84 Cr.242.26 Cr.215 Cr.176.56 Cr.
Change in Cash25.01 Cr.236.19 Cr.70.11 Cr.73.48 Cr.
Effect of Exchange Rate-9 Lakhs-23.82 Lakhs17.48 Lakhs72.16 Lakhs
Total Cash from Operating Activities336.75 Cr.265.77 Cr.44.67 Cr.83.42 Cr.
Depreciation46.90 Cr.35.80 Cr.30.86 Cr.23.01 Cr.
Other Cashflows from Investing Activities19.60 Cr.13.54 Cr.-1.50 Cr.-11.80 Cr.
Dividends Paid-22.69 Cr.-3.02 Cr.-32.52 Cr.-15.12 Cr.
Change to Inventory-48.31 Cr.59.22 Cr.-7.03 Cr.-8.98 Cr.
Change to Account Receivables-40.70 Cr.-50.39 Cr.-230.66 Cr.-33.92 Cr.
Other Cashflows from Financing Activities-1.46 Cr.-1.54 Cr.-49.54 Lakhs-6 Lakhs
Change to Net Income-11.98 Cr.-8.66 Cr.-24.83 Cr.3.49 Cr.
Capital Expenditures-91.18 Cr.-70.48 Cr.-76.73 Cr.-65.18 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research Development053.69 Cr.53.01 Cr.28.18 Cr.
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax385.82 Cr.313.61 Cr.269.46 Cr.226.87 Cr.
Minority Interest25.95 Cr.17.53 Cr.8.65 Cr.7.88 Lakhs
Net Income347.77 Cr.293.32 Cr.229.24 Cr.208.22 Cr.
Selling General Administrative115.30 Cr.102.61 Cr.67.77 Cr.47.10 Cr.
Gross Profit711.90 Cr.581.72 Cr.443.42 Cr.351.43 Cr.
Ebit347.77 Cr.293.32 Cr.229.24 Cr.208.22 Cr.
Operating Income347.77 Cr.293.32 Cr.229.24 Cr.208.22 Cr.
Other Operating Expenses201.93 Cr.95.20 Cr.61.78 Cr.44.49 Cr.
Interest Expense-70 Lakhs-1.58 Cr.-31.97 Lakhs-6 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense77.37 Cr.62.18 Cr.54.37 Cr.50.32 Cr.
Total Revenue1269.41 Cr.1062.35 Cr.863.95 Cr.649 Cr.
Total Operating Expenses921.64 Cr.769.02 Cr.634.71 Cr.440.78 Cr.
Cost of Revenue557.51 Cr.480.62 Cr.420.53 Cr.297.57 Cr.
Total Other Income Expense Net38.05 Cr.20.28 Cr.40.21 Cr.18.64 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.308.45 Cr.251.43 Cr.215.08 Cr.176.55 Cr.
Net Income Applicable to Common Shares299.84 Cr.242.26 Cr.215 Cr.176.56 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets10.85 Cr.7.23 Cr.5.01 Cr.2.10 Cr.
Capital Surplus02.12 Cr.2.12 Cr.1.62 Cr.
Total Liabilities226.44 Cr.160.24 Cr.169.18 Cr.109.53 Cr.
Stock Holder Equity1483.93 Cr.967.82 Cr.729.91 Cr.527.90 Cr.
Minority Interest25.95 Cr.17.53 Cr.8.65 Cr.7.88 Lakhs
Other Liabilities40.98 Cr.23.85 Cr.29.71 Cr.23.94 Cr.
Total Assets1736.32 Cr.1363.60 Cr.1125.75 Cr.742.51 Cr.
Common Stock15.16 Cr.15.12 Cr.15.12 Cr.15.12 Cr.
Retained Earnings0925.69 Cr.686.45 Cr.503.97 Cr.
Other Liabilities17.59 Cr.16.86 Cr.23.56 Cr.23.13 Cr.
Good Will05.37 Lakhs5.37 Lakhs0
Treasury Stock1468.77 Cr.24.87 Cr.26.20 Cr.7.17 Cr.
Other Assets97.19 Cr.7.91 Cr.10.04 Cr.11.95 Cr.
Cash462.99 Cr.231.57 Cr.49.92 Cr.49.32 Cr.
Current Liabilities207.68 Cr.142.85 Cr.144.32 Cr.86.11 Cr.
Long Term Asset Charges6.21 Cr.000
Short Long Term Debt50 Lakhs17.06 Cr.36.46 Cr.25.44 Lakhs
Other Stockholder Equity1468.77 Cr.24.87 Cr.26.20 Cr.7.17 Cr.
Property Plant Equipment293.45 Cr.311.92 Cr.287.55 Cr.234.43 Cr.
Total Cur. Assets1297.82 Cr.1035.80 Cr.822.53 Cr.493.68 Cr.
Long Term Investments37.01 Cr.66.35 Lakhs55.54 Lakhs33.30 Lakhs
Net Tangible Assets1473.08 Cr.960.52 Cr.724.84 Cr.525.80 Cr.
Short Term Investments51.97 Cr.225.38 Cr.170.83 Cr.101.33 Cr.
Net Receivables424.71 Cr.299.60 Cr.243.83 Cr.169.02 Cr.
Long Term Debt001.52 Lakhs28.68 Lakhs
Inventory227.31 Cr.179 Cr.238.23 Cr.37.44 Cr.
Accounts Payable163.18 Cr.88.50 Cr.64.13 Cr.60.47 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account